There are over 20 million Americans living with asthma -- and the numbers continue to increase. Inverseon, Inc. is a clinical-stage company developing drugs for chronic diseases of the lung.
Inverseon's asthma program has successfully completed two Phase IIa proof-of-concept human studies
|
